Classification
- Anatomical main groupAAlimentary tract and metabolism
- Therapeutic subgroupA10
- Pharmacological subgroupA10B
- Chemical subgroupA10BH
- Chemical substanceA10BH03Saxagliptin
Where it is registered
Each register with its number of medicines and a few of them.
Canada
Health Canada · 15 medicines
- Apo-Saxagliptin5 MG · Tablet · Apotex INC
- Apo-Saxagliptin2.5 MG · Tablet · Apotex INC
- Onglyza5 MG · Tablet · Astrazeneca Canada INC
- Onglyza2.5 MG · Tablet · Astrazeneca Canada INC
United States
FDA · 10 medicines
- Saxagliptin2.5MG BASE, 5MG BASE · tablet · Amneal
- Onglyza2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet · Astrazeneca AB



